Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CalciMedica Inc CALC

Healthcare
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more

Recent & Breaking News (NDAQ:CALC)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, FMIA, GRAY

PR Newswire February 15, 2023

GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY

Business Wire February 14, 2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, USER

PR Newswire December 13, 2022

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - VVNT, SAL, GRAY, APEN

PR Newswire December 9, 2022

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graybug Vision, Inc. (GRAY)

Newsfile December 6, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SAL

PR Newswire December 6, 2022

INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of Graybug Vision, Inc. - GRAY

Newsfile December 5, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RBA, WAFD, OPNT, GRAY

PR Newswire December 1, 2022

GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY

Business Wire November 23, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, OPNT

PR Newswire November 22, 2022

Shareholder Alert: Ademi LLP investigates whether Graybug Vision, Inc. has entered into a Fair Transaction with CalciMedica

PR Newswire November 22, 2022

GRAY STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Graybug Vision, Inc. Is Fair to Shareholders

Business Wire November 22, 2022

Graybug and CalciMedica Enter into Definitive Merger Agreement

GlobeNewswire November 21, 2022

Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022

GlobeNewswire November 10, 2022

Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments

GlobeNewswire August 11, 2022

Graybug to Present at the 2022 OIS Retina Innovation Summit

GlobeNewswire July 6, 2022

Graybug Announces Review of Strategic Alternatives

GlobeNewswire June 28, 2022

Graybug to Present Clinical Development Plan Update for GB-102 at the 2022 Clinical Trials at the Summit Meeting

GlobeNewswire May 19, 2022

Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments

GlobeNewswire May 10, 2022

Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting

GlobeNewswire April 27, 2022